Casdin Capital Portfolio

Casdin Capital 13F filer (CIK 0001534261).

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedHigh Turnover how tags are computed

Q4 2015 · 27 positions · Total reported value $92.31M · Top-10 concentration 73.1% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 26.1% · 6 new · 3 cut · 3 exited

Active Share (vs S&P 500): 99.8% · vs QQQ: 99.9% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +47.2% · vs SPY +32.4% · Prev Value $1.32B — last quarter positions weighted by this quarter price moves · ranking

In its Q4 2015 13F filing, Casdin Capital disclosed 27 equity positions with a combined reported value of $92.31M. The filing implies a focused portfolio: its ten largest positions account for 73.1% of reported value. HoldingsHub classifies the profile as Small / Focused / High Turnover.

The largest disclosed positions as of Q4 2015 were BPMC ($10.87M), SAGE ($8.34M), LOXO ($7.16M). By sector, the heaviest allocations are Health Care 32.3%, Other 67.7%.

Versus the prior quarter, Casdin Capital opened 6 new positions, trimmed 3 and fully exited 3, a turnover rate of 26.1% of positions.

The largest new positions opened in Q4 2015 were BPMC ($10.87M), SAGE ($8.34M), LOXO ($7.16M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q4 2015)

  • BPMC BLUEPRINT MEDICINES CORP · $10.87M
  • SAGE SAGE THERAPEUTICS INC · $8.34M
  • LOXO LOXO ONCOLOGY INC · $7.16M
  • CTMX CYTOMX THERAPEUTICS INC. · $6.70M
  • ONCE SPARK THERAPEUTICS INC · $6.57M
  • MYOK MYOKARDIA INC · $5.92M
  • GHDX GENOMIC HEALTH INC · $5.81M
  • ALNY ALNYLAM PHARMACEUTICALS INC · $5.65M

Fully Exited (vs previous quarter)

No tracked position was fully exited this quarter.

Insider Transactions (Form 4)

Latest Casdin Capital buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Casdin Capital is an SEC-registered 13F filer based in New York, NY, United States. As of Q2 2026 it reported 43 US equity positions with a combined value of $2.00B. HoldingsHub carries 43 quarters of its filings (Q4 2015–Q2 2026).

Firm Snapshot

  • Headquarters: NEW YORK, NY, United States
  • SEC registration: 801-110894 (status: Approved), registered 2017-07-31
  • Regulatory AUM (Form ADV): $2.87B as of 2026-03-31
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 5 private funds, of which 2 hedge funds

Portfolio Structure

  • 43 positions · $2.00B reported value (Q2 2026)
  • Top 10 holdings = 77.4% of reported value
  • Largest position: RVMD (REVOLUTION MEDICINES INC) at 24.2%
  • Average position size: $46.46M

Sector Tilt

  • Health Care 94.2%
  • Industrials 5.7%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 6 new, 9 added, 3 reduced, 3 exited
  • 25 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 32.3%
Other 67.7%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 412.50K $10.87M 11.77%
11.77%
New
2 143.01K $8.34M 9.03%
9.03%
New
3 251.50K $7.16M 7.75%
7.75%
New
4 321.02K $6.70M 7.26%
7.26%
New
5 145.00K $6.57M 7.12%
7.12%
New
6 403.87K $5.92M 6.41%
6.41%
New
7 165.00K $5.81M 6.29%
6.29%
New
8 60.00K $5.65M 6.12%
6.12%
New
9 332.50K $5.33M 5.77%
5.77%
New
10 236.86K $5.19M 5.62%
5.62%
New
11 20.00K $3.84M 4.16%
4.16%
New
12 9.00K $2.76M 2.99%
2.99%
New
13 310.00K $2.41M 2.61%
2.61%
New
14 32.16K $2.21M 2.40%
2.40%
New
15 65.00K $2.10M 2.28%
2.28%
New
16 250.00K $2.05M 2.22%
2.22%
New
17 30.00K $1.85M 2.00%
2.00%
New
18 17.00K $1.39M 1.51%
1.51%
New
19 20.00K $1.28M 1.39%
1.39%
New
20 170.00K $1.09M 1.19%
1.19%
New
21 75.00K $863.00K 0.94%
0.94%
New
22 17.50K $769.00K 0.83%
0.83%
New
23 25.00K $660.00K 0.71%
0.71%
New
24 10.00K $493.00K 0.53%
0.53%
New
25 70.00K $378.00K 0.41%
0.41%
New
26 5.00K $325.00K 0.35%
0.35%
New
27 15.00K $316.00K 0.34%
0.34%
New

FAQ

What did Casdin Capital buy in 2015-Q4?

In its 2015-Q4 13F filing, Casdin Capital reported 27 equity positions worth $92.31M in aggregate; its largest disclosed positions were BPMC ($10.87M), SAGE ($8.34M), LOXO ($7.16M).

How large is Casdin Capital's portfolio?

Casdin Capital reported $92.31M of long equity holdings across 27 positions as of 2015-Q4. Top-10 holdings account for 73.1% of reported value.

What is Casdin Capital's investment style?

HoldingsHub classifies the portfolio as Small / Focused / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/casdin/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →